BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zha H, Xu Z, Xu X, Lu X, Shi P, Xiao Y, Tsai HI, Su D, Cheng F, Cheng X, Chen H. PD-1 Cellular Nanovesicles Carrying Gemcitabine to Inhibit the Proliferation of Triple Negative Breast Cancer Cell. Pharmaceutics 2022;14:1263. [PMID: 35745835 DOI: 10.3390/pharmaceutics14061263] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Yu Z, He Q, Xu G. Effect of N6-methyladenosine (m6A) regulator-related immunogenes on the prognosis and immune microenvironment of breast cancer. Transl Cancer Res 2022;11:4303-14. [PMID: 36644186 DOI: 10.21037/tcr-22-1335] [Reference Citation Analysis]
2 Yang F, Wang M, Guan X. Exosomes and mimics as novel delivery platform for cancer therapy. Front Pharmacol 2022;13:1001417. [DOI: 10.3389/fphar.2022.1001417] [Reference Citation Analysis]